Legend Biotech (LEGN) Preferred Shares Issued (2020)

Legend Biotech (LEGN) reported Preferred Shares Issued of $160.4 million for Q4 2020.

Legend Biotech (LEGN) Preferred Shares Issued (2020) Analysis & Trends

Legend Biotech has reported Preferred Shares Issued for 1 years, with the latest figure at $160.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Regeneron Pharmaceuticals	63.59 Bn	54.83 Bn	3.31 Bn	-

Download Data

Date	Value
Dec 31, 2020	160.45 Mn
Dec 31, 2020	160.45 Mn